Biocryst Pharmaceuticals Ratios (2010-2026) | BCRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	99.41%	98.56%	99.11%	99.53%	99.62%	95.33%	97.00%	98.65%	98.92%	98.73%	98.33%	98.64%	98.45%	97.26%	95.37%	96.86%	98.29%	98.63%	-1,244.92%	96.56%
EBT Margin (Quarter)	-86.47%	-143.44%	-32.92%	-148.06%	-88.51%	-54.07%	-89.84%	-76.57%	-90.42%	-41.29%	-67.62%	-37.75%	-11.43%	-11.48%	-19.76%	0.52%	3.97%	7.61%	35,030.65%	-460.84%
EBIT Margin (Quarter)	-59.21%	-108.76%	-110.64%	-100.07%	-52.98%	-23.01%	-58.22%	-41.31%	-25.10%	-13.74%	-45.68%	-15.62%	8.01%	6.57%	-3.43%	14.59%	18.23%	18.56%	36,777.54%	-448.55%
EBITDA Margin (Quarter)	-59.21%	-108.76%	-110.64%	-100.07%	-52.98%	-23.01%	-58.22%	-41.31%	-25.10%	-13.74%	-45.68%	-15.62%	8.01%	6.57%	-3.43%	14.59%	18.23%	18.56%	36,777.54%	-448.55%
Operating Margin (Quarter)	-59.21%	-108.76%	-110.64%	-100.07%	-52.98%	-23.01%	-58.22%	-41.31%	-25.10%	-13.74%	-45.68%	-15.62%	8.01%	6.57%	-3.43%	14.59%	18.23%	18.56%	36,777.54%	-448.55%
Net Margin (Quarter)	-86.47%	-143.44%	-37.70%	-148.62%	-89.82%	-56.08%	-89.94%	-77.54%	-91.31%	-41.67%	-66.09%	-38.14%	-11.59%	-11.99%	-20.37%	0.02%	3.11%	8.09%	34,723.87%	-461.48%
FCF Margin (Quarter)	-52.49%	-57.67%	-71.18%	-156.65%	-42.73%	-43.02%	-30.64%	-69.31%	-23.37%	-24.08%	-7.82%	-58.13%	-1.04%	6.66%	-3.62%	-18.91%	24.63%	25.74%	41,386.72%	-39.89%
Efficiency
Inventory Average (Quarter)	7.75M	11.89M	14.73M	16.09M	19.89M	25.20M	27.28M	27.50M	27.25M	28.33M	29.16M	29.23M	17.12M	6.01M	7.82M	7.48M	5.96M	5.14M	5.32M	5.69M
Assets Average (Quarter)	280.86M	271.52M	426.96M	557.94M	519.13M	534.57M	554.30M	529.87M	519.81M	526.40M	519.94M	492.43M	470.16M	481.84M	490.84M	485.23M	468.62M	451.81M	480.29M	489.61M
Invested Capital (Quarter)							2.63M				4.43M	4.15M	3.80M	3.92M	3.96M	4.11M	3.66M	3.18M	2.75M	2.41M
Asset Utilization Ratio (Quarter)	0.28	0.42	0.37	0.34	0.39	0.45	0.49	0.55	0.59	0.60	0.64	0.72	0.81	0.86	0.92	1.04	1.19	1.33	0.98	0.98
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-2.19	-3.16	1.34	-2.10	-1.45	-0.70	-1.75	-1.04	-0.72	-0.44	-0.47	-0.59	0.35	0.31	-0.06	0.90	1.38	1.02	18.42	-9.88
Debt Ratio (Quarter)	0.46	0.50	0.51	0.27	0.28	0.40	0.42	0.46	0.55	0.57	0.63	0.71	0.73	0.71	0.71	0.73	0.61	0.52	0.07	0.94
Times Interest Earned (Quarter)	-2.19	-3.16	1.34	-2.10	-1.45	-0.70	-1.75	-1.04	-0.72	-0.44	-0.47	-0.59	0.35	0.31	-0.06	0.90	1.38	1.02	18.42	-9.88
Valuation
Enterprise Value (Quarter)	-218.43M	-199.60M	-507.60M	-443.47M	-417.48M	-426.86M	-121.02M	-244.49M	-410.67M	-248.27M	-388.99M	-336.55M	-195.41M	-330.01M	-320.85M	-190.19M	-172.50M	-212.87M	-185.21M	-67.66M
Return Ratios
Return on Sales (Quarter)	-0.01%	-0.01%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	3.47%	-0.05%
Return on Capital Employed (Quarter)	-106.64%	-129.03%	-54.98%	-36.97%	-42.82%	-34.07%	-33.08%	-28.53%	-26.48%	-24.64%	-28.03%	-24.10%	-17.68%	-12.40%	-0.77%	9.60%	18.60%	29.09%	119.97%	-129.78%
Return on Invested Capital (Quarter)								-0.49%	-0.43%	-0.41%	-0.29%	-0.14%	-0.06%	-0.03%	0.00%	0.02%	0.04%	0.07%	0.24%	-0.30%
Return on Assets (Quarter)	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	-0.01%

Research Tools

Developers

Biocryst Pharmaceuticals Ratios (2010-2026) | BCRX

Research Tools

Developers

Biocryst Pharmaceuticals Ratios (2010-2026) | BCRX

Create an account

Sign In

Reset Password